With sweeping advances in targeting and manipulations of genome and transcriptome, medical biotechnology offers unprecedented selectivity and control of a wide variety of biological processes, forging new opportunities for therapeutic interventions. This perspective summarizes the state-of-the-art gene therapies enabled by recent innovations with an emphasis on the expanding portfolio of molecular targets that govern the activity and functions of primary sensory neurons, which might be exploited for the effective treatment of chronic pain.